Denise Scots-Knight has an estimated net worth of $17.2 Million. This is based on reported shares across multiple companies, which include Mereo BioPharma Group plc, VIACELL INC, Elanco Animal Health Inc, ALBIREO PHARMA, INC., OncoMed Pharmaceuticals Inc, and IDENIX PHARMACEUTICALS INC.

2024 was Denise Scots-Knight's most active year for acquiring shares with 5 total transactions. Denise Scots-Knight's most active month to acquire stocks was the month of May. 2014 was Denise Scots-Knight's most active year for disposing of shares, totalling 9 transactions. Denise Scots-Knight's most active month to dispose stocks was the month of July. 2005 saw Denise Scots-Knight paying a total of $0.00 for 1,702,184 shares, this is the most they've acquired in one year. In 2005 Denise Scots-Knight cashed out on 2,321,682 shares for a total of $12,973,953.78, their largest year based on trade value.